David Weill, Director at TransMedics Group, Inc. (TMDX), sold 10,000 shares at $138.64 ($1.4M) on 2025-12-03, disclosed to the SEC on 2025-12-05.
Open-market sale of $1.4M TMDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.64 | 5,000 | $693K | 50.0% |
| 2 | $138.64 | 5,000 | $693K | 50.0% |
| Total | $138.64 avg | 10,000 | $1.4M | 100% |
| Filing → |
| TMDX | SELL | 2025-05-23 | $181K | — | Filing → |
| TMDX | SELL | 2024-05-31 | $338K | — | Filing → |
| TMDX | SELL | 2024-05-14 | $325K | — | Filing → |